239 related articles for article (PubMed ID: 32798995)
1. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
Wisneski AD; Jin C; Huang CY; Warren R; Hirose K; Nakakura EK; Corvera CU
J Surg Res; 2020 Dec; 256():476-485. PubMed ID: 32798995
[TBL] [Abstract][Full Text] [Related]
2. Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database.
Jones TJ; Murphy AE; Tameron A; Hussain LR; Grannan K; Guend H; Dunki-Jacobs EM; Lee DY
J Surg Res; 2019 Jun; 238():35-40. PubMed ID: 30735964
[TBL] [Abstract][Full Text] [Related]
3. ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection.
Sanyal S; Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D
J Gastrointest Cancer; 2021 Mar; 52(1):106-112. PubMed ID: 31853827
[TBL] [Abstract][Full Text] [Related]
4. Effect of Time to Surgery of Colorectal Liver Metastases on Survival.
Chen EY; Mayo SC; Sutton T; Kearney MR; Kardosh A; Vaccaro GM; Billingsley KG; Lopez CD
J Gastrointest Cancer; 2021 Mar; 52(1):169-176. PubMed ID: 32086781
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
7. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
[TBL] [Abstract][Full Text] [Related]
8. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
9. Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey.
Bonney GK; Coldham C; Adam R; Kaiser G; Barroso E; Capussotti L; Laurent C; Verhoef C; Nuzzo G; Elias D; Lapointe R; Hubert C; Lopez-Ben S; Krawczyk M; Mirza DF;
J Surg Oncol; 2015 May; 111(6):716-24. PubMed ID: 25864987
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in primary and iterative surgery of colorectal liver metastases.
Tonelli F; Leo F; Nobili S; Mini E; Batignani G
J Chemother; 2010 Oct; 22(5):358-63. PubMed ID: 21123161
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
12. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
[TBL] [Abstract][Full Text] [Related]
14. Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases?
Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Mitsuhashi N; Takeuchi D; Iida A; Miyazaki M
J Gastrointest Surg; 2008 Aug; 12(8):1391-8. PubMed ID: 18491195
[TBL] [Abstract][Full Text] [Related]
15. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
16. Impact of parenchymal preserving surgery on survival and recurrence after liver resection for colorectal liver metastasis.
Pandanaboyana S; Bell R; White A; Pathak S; Hidalgo E; Lodge P; Prasad R; Toogood G
ANZ J Surg; 2018 Jan; 88(1-2):66-70. PubMed ID: 27111217
[TBL] [Abstract][Full Text] [Related]
17. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
[TBL] [Abstract][Full Text] [Related]
19. Impact of the strategy for curative treatment of synchronous colorectal cancer liver metastases.
Raoux L; Maulat C; Mokrane FZ; Fares N; Suc B; Muscari F
J Visc Surg; 2020 Aug; 157(4):289-299. PubMed ID: 32089468
[TBL] [Abstract][Full Text] [Related]
20. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]